News
- Author:
- Michele G. Sullivan
Publish date: January 29, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 28, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 27, 2014
Major finding: A metabolite of the banned pesticide DDT was associated with a fourfold increase in the risk of Alzheimer’s disease.Data sour...
News
- Author:
- Michele G. Sullivan
Publish date: January 24, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 22, 2014
Major finding: No clinical gains were detected with either bapineuzumab or solanezumab among Alzheimer’s patients on the primary endpoints o...
News
- Author:
- Michele G. Sullivan
Publish date: January 22, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 22, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 21, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 16, 2014
News
- Author:
- Michele G. Sullivan
Publish date: January 14, 2014
Major finding: By week 4, patients achieved a HCV-RNA level of less than 25 IU/mL; 97% maintained that level through the end of treatment.
News
- Author:
- Michele G. Sullivan
Publish date: January 9, 2014
Major finding: Fourteen pregnancies (66%) – including one set of twins – were conceived without assisted reproduction techniques.Data ...
News
- Author:
- Michele G. Sullivan
Publish date: January 8, 2014
Major finding: Anti-CCP–positive women using DMARDs were almost three times more likely to die (hazard ratio, 2.8) than were women without R...
News
- Author:
- Michele G. Sullivan
Publish date: January 8, 2014
Major finding: In older, more frail patients, lower limb revascularization cost up to $90,000 less over 10 years, and yielded better clinical outc...
News
- Author:
- Michele G. Sullivan
Publish date: January 7, 2014
Major finding: By week 4, patients achieved a HCV-RNA level of less than 25 IU/mL; 97% maintained that level through the end of treatment.
News
- Author:
- Michele G. Sullivan
Publish date: December 31, 2013
Major finding: Compared with placebo, 2,000 IU/day of vitamin E was associated with a significantly 19% slowing of functional decline in patients ...
